These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36472287)

  • 21. Gastroesophageal Reflux Disease in Obese Patients.
    Valezi AC; Herbella FAM; Schlottmann F; Patti MG
    J Laparoendosc Adv Surg Tech A; 2018 Aug; 28(8):949-952. PubMed ID: 30004267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre and post-operative evaluation of gastroesophageal reflux and esophageal motility in neurologically impaired children using combined pH-multichannel intraluminal impedance measurements.
    Fukahori S; Asagiri K; Ishii S; Tanaka Y; Kojima S; Saikusa N; Koga Y; Yoshida M; Masui D; Komatsuzaki N; Seki Y; Yagi M
    Pediatr Surg Int; 2013 Jun; 29(6):545-51. PubMed ID: 23519548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of obesity treatment on gastroesophageal reflux disease.
    Khan A; Kim A; Sanossian C; Francois F
    World J Gastroenterol; 2016 Jan; 22(4):1627-38. PubMed ID: 26819528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prostaglandin I2 (PG I2; prostacyclin) synthesis by human gastric mucosa (author's transl)].
    Sinzinger H; Silberbauer K; Seyfried H; Winter M
    Wien Klin Wochenschr; 1979 Nov; 91(22):768-71. PubMed ID: 390892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric greater curvature plication combined with Nissen fundoplication in the treatment of gastroesophageal reflux disease and obesity.
    Ospanov O; Maleckas A; Orekeshova A
    Medicina (Kaunas); 2016; 52(5):283-290. PubMed ID: 27707580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of vasodilatory prostaglandins with respect to cAMP-mediated phosphorylation of a target substrate in intact human platelets.
    Nolte C; Eigenthaler M; Schanzenbächer P; Walter U
    Biochem Pharmacol; 1991 Jul; 42(2):253-62. PubMed ID: 1713458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic Nissen Fundoplication Plus Mid-gastric Plication for Treatment of Obese Patients with Gastroesophageal Reflux Disease.
    Talha A; Ibrahim M
    Obes Surg; 2018 Feb; 28(2):437-443. PubMed ID: 28801746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.
    Weksler BB; Marcus AJ; Jaffe EA
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3922-6. PubMed ID: 333448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients.
    Ortiz V; Ponce M; Fernández A; Martínez B; Ponce JL; Garrigues V; Ponce J
    Obesity (Silver Spring); 2006 Apr; 14(4):696-700. PubMed ID: 16741272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostacyclin: A major prostaglandin in the regulation of adipose tissue development.
    Rahman MS
    J Cell Physiol; 2019 Apr; 234(4):3254-3262. PubMed ID: 30431153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdiaphragmatic Pressure Gradient (TPG) Has a Central Role in the Pathophysiology of Gastroesophageal Reflux Disease (GERD) in the Obese and it Correlates with Abdominal Circumference but Not with Body Mass Index (BMI).
    de Mello Del Grande L; Herbella FAM; Katayama RC; Lima WG; Patti MG
    Obes Surg; 2020 Apr; 30(4):1424-1428. PubMed ID: 31858395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of prostaglandin I2 on cyclical reductions of coronary blood flow.
    Uchida Y; Murao S
    Jpn Circ J; 1979 Jul; 43(7):645-52. PubMed ID: 387990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical management of gastroesophageal reflux disease in the obese patient.
    Nau P; Jackson HT; Aryaie A; Ibele A; Shouhed D; Lo Menzo E; Kurian M; Khaitan L;
    Surg Endosc; 2020 Jan; 34(1):450-457. PubMed ID: 31720811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
    Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugation of 15-keto-prostaglandins by glutathione S-transferases.
    Chaudhari A; Anderson MW; Eling TE
    Biochim Biophys Acta; 1978 Oct; 531(1):56-64. PubMed ID: 708749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varying marginal ulcer rates in patients undergoing laparoscopic Roux-en-Y gastric bypass for morbid obesity versus gastroesophageal reflux disease: is the acid pocket to blame?
    Gilmore MM; Kallies KJ; Mathiason MA; Kothari SN
    Surg Obes Relat Dis; 2013; 9(6):862-6. PubMed ID: 23522621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to 5,6-dihydroprostaglandin I2 trap endogenously produced prostaglandin I2 in the rat circulation.
    Pace-Asciak CR; Carrara MC; Levine L
    Biochim Biophys Acta; 1980 Nov; 620(2):186-92. PubMed ID: 7002219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilization mechanism of prostacyclin by human serum: an approach by binding kinetics using a stable prostaglandin I2 analogue, iloprost.
    Tsai AL; Wu KK
    Biochim Biophys Acta; 1987 Apr; 924(1):67-74. PubMed ID: 2435326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroesophageal Reflux Disease, Obesity, and Roux-en-Y Gastric Bypass: Complex Relationship-a Narrative Review.
    Suter M
    Obes Surg; 2020 Aug; 30(8):3178-3187. PubMed ID: 32424794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Specific features of gastroesophageal reflux disease associated with obesity and overweight].
    Livzan MA; Lapteva IV; Krolevets TS; Kiselev IE
    Ter Arkh; 2016; 88(2):21-27. PubMed ID: 27030179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.